111 related articles for article (PubMed ID: 8710023)
1. [Predictive testing for p53-mutations; ethical considerations. National Work Group Hereditary Mamma Carcinoma].
de Wert GM
Ned Tijdschr Geneeskd; 1996 Jun; 140(26):1350-3. PubMed ID: 8710023
[No Abstract] [Full Text] [Related]
2. [Hereditary mutations in the p53 tumor suppressor gene; significance for clinical practice. National Work Group Hereditary Mamma Carcinoma].
Menko FH; Nooy MA; Vasen HF
Ned Tijdschr Geneeskd; 1996 Jun; 140(26):1347-50. PubMed ID: 8710022
[No Abstract] [Full Text] [Related]
3. Genetic counselling and genetic testing in hereditary gastrointestinal cancer syndromes.
Raymond VM; Everett JN
Best Pract Res Clin Gastroenterol; 2009; 23(2):275-83. PubMed ID: 19414152
[TBL] [Abstract][Full Text] [Related]
4. [Genetic testing and counseling for familial tumor syndromes].
Katai M; Sakurai A; Fukushima Y
Gan To Kagaku Ryoho; 2002 Apr; 29(4):502-7. PubMed ID: 11977532
[TBL] [Abstract][Full Text] [Related]
5. Germline TP53 alterations in Finnish breast cancer families are rare and occur at conserved mutation-prone sites.
Rapakko K; Allinen M; Syrjäkoski K; Vahteristo P; Huusko P; Vähäkangas K; Eerola H; Kainu T; Kallioniemi OP; Nevanlinna H; Winqvist R
Br J Cancer; 2001 Jan; 84(1):116-9. PubMed ID: 11139324
[TBL] [Abstract][Full Text] [Related]
6. Mutations in familial cancer.
Wright PA; Wynford-Thomas D
J Pathol; 1994 Feb; 172(2):167-70. PubMed ID: 8169748
[No Abstract] [Full Text] [Related]
7. A social network analysis of communication about hereditary nonpolyposis colorectal cancer genetic testing and family functioning.
Koehly LM; Peterson SK; Watts BG; Kempf KK; Vernon SW; Gritz ER
Cancer Epidemiol Biomarkers Prev; 2003 Apr; 12(4):304-13. PubMed ID: 12692104
[TBL] [Abstract][Full Text] [Related]
8. Hereditary cancers in children and ethical and psychosocial implications.
MacDonald DJ; Lessick M
J Pediatr Nurs; 2000 Aug; 15(4):217-25. PubMed ID: 10969494
[TBL] [Abstract][Full Text] [Related]
9. Hereditary breast-ovarian cancer: clinical findings and medical management.
Marshall M; Solomon S
Plast Surg Nurs; 2007; 27(3):124-7. PubMed ID: 17901820
[TBL] [Abstract][Full Text] [Related]
10. [Hereditary diseases are family diseases].
Kooij L; Tijmstra TJ
Ned Tijdschr Geneeskd; 1996 Mar; 140(9):473-5. PubMed ID: 8628432
[No Abstract] [Full Text] [Related]
11. Genetic jeopardy and the new clairvoyance.
Wexler NS
Prog Med Genet; 1985; 6():277-304. PubMed ID: 2941821
[No Abstract] [Full Text] [Related]
12. Are you prepared for these new ethical dilemmas?
Bedway B
Med Econ; 1996 Feb; 73(4):81-3, 88, 90. PubMed ID: 10154692
[No Abstract] [Full Text] [Related]
13. Genetics in kidney disease: how much do we want to know?
Kielstein R; Sass HM
Am J Kidney Dis; 2002 Mar; 39(3):637-52. PubMed ID: 11877585
[No Abstract] [Full Text] [Related]
14. Genetics of cancer: current knowledge and future possibilities.
Evans DG
Hosp Med; 1998 Dec; 59(12):920-3. PubMed ID: 10696352
[TBL] [Abstract][Full Text] [Related]
15. Hereditary breast cancer syndromes in a Turkish population. Results of molecular germline analysis.
Güran S; Ozet A; Dede M; Gille JJ; Yenen MC
Cancer Genet Cytogenet; 2005 Jul; 160(2):164-8. PubMed ID: 15993273
[TBL] [Abstract][Full Text] [Related]
16. [Hereditary carcinoma: pathogenesis and diagnosis].
Jungck M
Zentralbl Chir; 2000; 125 Suppl 1():8-11. PubMed ID: 10929639
[TBL] [Abstract][Full Text] [Related]
17. Genetic mutations in thyroid carcinoma.
Taccaliti A; Boscaro M
Minerva Endocrinol; 2009 Mar; 34(1):11-28. PubMed ID: 19209125
[TBL] [Abstract][Full Text] [Related]
18. Scoping the family history: assessment of Lynch syndrome (hereditary nonpolyposis colorectal cancer) in primary care settings--a primer for nurse practitioners.
Maradiegue A; Jasperson K; Edwards QT; Lowstuter K; Weitzel J
J Am Acad Nurse Pract; 2008 Feb; 20(2):76-84. PubMed ID: 18271762
[TBL] [Abstract][Full Text] [Related]
19. Molecular genetics and management strategies in hereditary cancer syndromes.
Hanna NN; Mentzer RM
J Ky Med Assoc; 2003 Mar; 101(3):100-7. PubMed ID: 12674901
[TBL] [Abstract][Full Text] [Related]
20. Germ-line p53 mutations predispose to a wide spectrum of early-onset cancers.
Nichols KE; Malkin D; Garber JE; Fraumeni JF; Li FP
Cancer Epidemiol Biomarkers Prev; 2001 Feb; 10(2):83-7. PubMed ID: 11219776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
